Rezultaty - Ouzama Henry

Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study od Remon Abu-Elyazeed, William Jennings, Randall Severance, Michael Noss, Adrian Caplanusi, Michael Povey, Ouzama Henry

Connect to this object online.

Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England od Megan Riley, Dimitra Lambrelli, Sophie Graham, Ouzama Henry, Andrea Sutherland, Alexander Schmidt, Nicola Sawalhi-Leckenby, Robert Donaldson, Sonia K. Stoszek

Connect to this object online.

Adverse infant outcomes following low-risk pregnancies in England: a retrospective cohort study od Megan Riley, Dimitra Lambrelli, Sophie Graham, Ouzama Henry, Andrea Sutherland, Alexander Schmidt, Nicola Sawalhi-Leckenby, Robert Donaldson, Sonia K. Stoszek

Connect to this object online.

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-... od Saul N. Faust, Maguelone Le Roy, Chitsanu Pancharoen, Miguel Angel Rodriguez Weber, Katrina Cathie, Ulrich Behre, Jolanta Bernatoniene, Matthew D. Snape, Klaus Helm, Carlos Eduardo Medina Pech, Ouzama Henry, Carmen Baccarini, Michael Povey, Paul Gillard

Connect to this object online.

Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin od Andrea A. Berry, Remon Abu-Elyazeed, Clemente Diaz-Perez, Maurice A. Mufson, Christopher J. Harrison, Michael Leonardi, Jerry D. Twiggs, Christopher Peltier, Stanley Grogg, Antonio Carbayo, Steven Shapiro, Michael Povey, Carmen Baccarini, Bruce L. Innis, Ouzama Henry

Connect to this object online.